Published date:
Wednesday, 30 November, 2011
Body:
An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries.
Website:
Introduction:
<p><em style="font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12.16px; line-height: 20.672px;">Please contact us at <a href="mailto:mvi_info@path.org">mvi_info@path.org</a> for the French version of this article.</em></p>